Alena Khromava | Senior Director and Head of Pharmacoepidemiology and Risk Management
Sanofi Pasteur

Day 2, April 8 @ 17:10

Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

• Evaluating vaccine safety in children and other at-risk populations
  • E.g. RSV and Pertussis, Live attenuated vs subunit
• What are the benefits of RCTs and large databases and how can they be improved?
• How can we ensure we are taking all parameters into account e.g. what time of year is the vaccine given?
• How do we decide which signals are meaningful?
• Do we need to revisit the influenza & narcolepsy issue?
• The need for better databases in LMICs – how do you recognize safety signals? How can they be implemented?

Deshayne Fell, Assistant Professor, Epidemiology And Public Health, University of Ottawa

×

Deshayne Fell / Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

Deshayne Fell, Assistant Professor, Epidemiology And Public Health,
University of Ottawa

Dr. Deshayne Fell is an Assistant Professor in the School of Epidemiology and Public Health at the University of Ottawa and a Scientist in the Children's Hospital of Eastern Ontario Research Institute. Dr. Fell’s research uses large, linked population databases and registries to improve our...

CloseMore

Alena Khromava, Senior Director and Head of Pharmacoepidemiology and Risk Management, Sanofi Pasteur

×

Alena Khromava / Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

Alena Khromava, Senior Director and Head of Pharmacoepidemiology and Risk Management,
Sanofi Pasteur

Prior to joining Sanofi Pasteur in 2004, Alena completed Epidemic Intelligence Service at the US Centers for Disease Control and Prevention in Immunization Safety Branch. She also worked as a medical epidemiologist on STDs, HIV/AIDS and Multidrug resistant tuberculosis in Moscow, Russia. Alena is...

CloseMore

Jeff Roberts, Associate Director For Scientific Affairs, FDA

×

Jeff Roberts / Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

Jeff Roberts, Associate Director For Scientific Affairs,
FDA

Dr. Jeff Roberts is the Associate Director for Scientific Affairs in the Office of Vaccines Research and Review. He came to FDA in 2008, serving first as a Medical Officer then as Clinical Branch Chief in the Division of Vaccines and Related Product Applications before assuming the Associate...

CloseMore

Tom Shimabukuro, Deputy Director, Immunization Safety Office, Centers for Disease Control and Prevention

×

Tom Shimabukuro / Vaccine safety surveillance: what can we do to improve surveillance studies and databases?

Tom Shimabukuro, Deputy Director, Immunization Safety Office,
Centers for Disease Control and Prevention

Dr. Tom Shimabukuro is the deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The CDC’s Immunization Safety Office conducts post-licensure safety monitoring of U.S. vaccines. Dr. Shimabukuro has also served as the Vaccine...

CloseMore